WO2011033356A1 - Composicin farmacutica para bajar de peso y procedimiento para obtener la misma - Google Patents Composicin farmacutica para bajar de peso y procedimiento para obtener la misma Download PDF Info Publication number WO2011033356A1 WO2011033356A1 PCT/IB2010/002270 IB2010002270W WO2011033356A1 WO 2011033356 A1 WO2011033356 A1 WO 2011033356A1 IB 2010002270 W IB2010002270 W IB 2010002270W WO 2011033356 A1 WO2011033356 A1 WO 2011033356A1 Authority WO WIPO (PCT) Prior art keywords orlistat pharmaceutical composition further characterized diluent carnitine Prior art date Legal status (The legal status is an assumption and is not a legal conclusion
K., & Goldstein, A
doi: 10.1080/15265161.2025.2554795 Sophie C Hofferberth , Timothy Kelley , Aimee K Armstrong , Christine Heyninck-Jantz , Alaena Maiorano , Michael Colson , Frederick J Schoen , Changfu Wu , Nicole Ibrahim , Justin T Tretter , Megan D Mueller 0, Richard W Bianco , John P Carney , Luc Behr , Christopher K Breuer , Jason Beith , Martijn Cox , Eric N Feins , Eric Vang , Larry Wood , Robert T Tranquillo , D Scott Lim , Andrew M Taylor , Andrew Redington , John P Cheatham, Doff B McElhinney , Pedro J Del Nido , Ajit Yoganathan
We think we know why the cardiologist ignored the two measurements of the left atrium alone and instead focused only upon the two LA/Ao ratios
acetyl L-carnitine may conceivably play a role in the inflammation and fibrosis typical of the disease without, however, in any way suggesting the use of propionyl L-carnitine, which, in any event, is a different molecule
